SO
TRVI icon

STRS Ohio’s Trevi Therapeutics TRVI Stock Holding History

STRS Ohio’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Sell
12,800
-10,900
-46% -$122K ﹤0.01% 1604
2025
Q4 		$297K Sell
23,700
-8,600
-27% -$99.4K ﹤0.01% 1338
2025
Q3 		$296K Buy
32,300
+8,300
+35% +$62.2K ﹤0.01% 1342
2025
Q2 		$131K Buy
24,000
+15,800
+193% +$98.3K ﹤0.01% 1788
2025
Q1 		$51.6K Hold
8,200
– – ﹤0.01% 1767
2024
Q4 		$33.8K Hold
8,200
– – ﹤0.01% 1771
2024
Q3 		$27.4K Hold
8,200
– – ﹤0.01% 1873
2024
Q2 		$24.4K Hold
8,200
– – ﹤0.01% 1881
2024
Q1 		$28K Sell
8,200
-500
-6% -$1.12K ﹤0.01% 1827
2023
Q4 		$11K Hold
8,700
– – ﹤0.01% 1873
2023
Q3 		$18K Hold
8,700
– – ﹤0.01% 1880
2023
Q2 		$20K Buy
+8,700
New +$21.9K ﹤0.01% 1886

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return